In a shocking turn of events, Dr. Evanson Kamuri, the Chief Executive Officer of Kenyatta National Hospital (KNH), has been sacked under what sources claim is a calculated move by cartels within the Ministry of Health to facilitate the irregular supply of hospital equipment.

The sudden dismissal of Dr. Kamuri, who was set to proceed on terminal leave in October 2025 upon reaching retirement age, has raised eyebrows and sparked allegations of a cover-up to push through a controversial procurement deal.

According to reliable sources, the primary motive behind Dr. Kamuri’s abrupt exit is to clear the way for a scheme to supply medical equipment to KNH through a Fixed Fee Contract (FFC).

The deal, reportedly worth hundreds of millions of shillings, is said to be orchestrated by powerful cartels within the Ministry of Health. Insiders allege that the rush to remove Dr. Kamuri is directly linked to this plan, as his presence could have posed a challenge to the irregular procurement process.

At the center of the controversy is a Shs 400 million oxygen plant, which sources confirm was procured by the Ministry of Health, not KNH.

Dr. Kamuri and the hospital’s management were reportedly not involved in the procurement process, raising questions about why the CEO is being targeted.

“The oxygen plant was a Ministry initiative, not a KNH project. Dr. Kamuri had no role in its procurement, yet he is being scapegoated,” a senior hospital official said on condition of anonymity.

Dr. Kamuri, a respected figure in Kenya’s healthcare sector, was due to retire and had been scheduled to begin his terminal leave in October 2025.

However, his sudden sacking has fueled speculation that the move was orchestrated to prevent him from scrutinizing or potentially exposing the alleged irregularities in the equipment supply scheme.

“This is a cover-up,” a source close to the matter stated.

“The cartels want to fast-track the process before new leadership at KNH can question the deal.”

The use of a Fixed Fee Contract for the equipment supply has also raised red flags. Critics argue that such contracts are often exploited to bypass competitive bidding processes, allowing connected individuals to secure lucrative deals at inflated costs.

The alleged scheme is said to involve well-connected players within the Ministry of Health who stand to benefit financially from the irregular procurement.

As the controversy unfolds, the Ministry of Health has remained tight-lipped, with no official statement addressing the allegations.